Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zhengye Biotechnology Holding Limited

5.91
-0.3800-6.04%
Post-market: 6.200.2900+4.91%16:39 EDT
Volume:224.45K
Turnover:1.38M
Market Cap:280.08M
PE:96.68
High:6.70
Open:6.37
Low:5.66
Close:6.29
Loading ...

Zhengye Biotechnology Receives NASDAQ Notice for Delayed 2024 Annual Report Filing

Reuters
·
24 May

Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F

GlobeNewswire
·
24 May

Zhengye Biotechnology Holding Ltd trading resumes

TIPRANKS
·
13 May

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
13 May

Zhengye Biotechnology Holding Ltd trading resumes

TIPRANKS
·
08 May

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
08 May

Zhengye Biotechnology Holding Ltd trading resumes

TIPRANKS
·
29 Apr

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
29 Apr

Zhengye Biotechnology Holding Ltd trading resumes

TIPRANKS
·
22 Apr

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
22 Apr

Zhengye Biotechnology Holding Ltd trading resumes

TIPRANKS
·
15 Apr

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
15 Apr

Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%?

Simply Wall St.
·
07 Apr

Zhengye Biotechnology Holding Ltd trading resumes

TIPRANKS
·
26 Mar

Zhengye Biotechnology Holding Ltd trading halted, volatility trading pause

TIPRANKS
·
26 Mar

BRIEF-Zhengye Biotechnology Holding Ltd Appointed Aiden Han As Co-Chief Executive Officer

Reuters
·
07 Mar

Zhengye Biotechnology Holding Ltd -Appointed Aiden Han as Co-Chief Executive Officer

THOMSON REUTERS
·
07 Mar

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option

GlobeNewswire
·
15 Jan

Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering

THOMSON REUTERS
·
09 Jan

BRIEF-Zhengye Biotechnology Holding Limited Announces Pricing Of Initial Public Offering

Reuters
·
07 Jan